AI assistant
CLEARONE INC — Director's Dealing 2014
Dec 17, 2014
35252_dirs_2014-12-16_7a56f05f-83e9-4df3-b587-556d2c38fe0f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLEARONE INC (CLRO)
CIK: 0000840715
Period of Report: 2014-03-11
Reporting Person: HAKIMOGLU ZEYNEP (Director, PRESIDENT & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-11 | Common Stock | M | 60000 | $5.55 | Acquired | 159181 | Direct |
| 2014-12-12 | Common Stock | S | 6246 | $9.92 | Disposed | 152935 | Direct |
| 2014-12-15 | Common Stock | S | 6000 | $9.55 | Disposed | 146935 | Direct |
| 2014-12-16 | Common Stock | S | 4754 | $9.53 | Disposed | 142181 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-11 | Stock Option (Right to Buy) | $5.55 | M | 60000 | Disposed | 2014-07-26 | Common Stock (60000) | Direct |
Footnotes
F1: The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $9.92 to $9.93. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F2: The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $9.50 to $9.61. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F3: The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $9.50 to $9.60. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F4: One-third of the options vested on the first anniversary of the date of grant, which was July 26, 2004. The remaining options vested in equal monthly increments over the subsequent 24-month period.
F5: These shares were sold under a Rule 10b5-1 plan.